《ARMS技术联合Taqman探针检测100例非小细胞肺癌EGFR基因突变》

2021/11/29

950

【摘要】表皮生长因子受体（epidermal growth factor receptor，EGFR）基因突变是决定表皮生长因子受体酪氨酸激酶抑制剂（EGFR tyrosine kinase inhibitor，EGFR-TKI）疗效最重要的预测因子，对EGFR基因突变进行检测，对指导患者个体化治疗具有重要意义。

【关键词】扩增阻滞突变系统,Taqman探针,表皮生长因子受体,突变检测,肺肿瘤

上一篇：《A Comparison of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry and Surface Plasmon Resonance for Genotyping of High-Risk Human Papillomaviruses 》

下一篇《c A Comparison of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry and Surface Plasmon Resonance for Genotyping of High-Risk Human Papillomaviruses 》

EARN MORE